Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 2
1952 1
1953 5
1954 3
1955 2
1956 2
1957 5
1958 3
1959 7
1960 6
1961 1
1962 13
1963 11
1964 17
1965 17
1966 4
1967 10
1968 8
1969 11
1970 9
1971 8
1972 10
1973 4
1974 6
1975 14
1976 7
1977 18
1978 13
1979 17
1980 11
1981 15
1982 16
1983 11
1984 20
1985 36
1986 45
1987 48
1988 70
1989 73
1990 70
1991 79
1992 90
1993 95
1994 111
1995 120
1996 146
1997 148
1998 175
1999 189
2000 216
2001 224
2002 270
2003 299
2004 387
2005 478
2006 552
2007 607
2008 682
2009 801
2010 950
2011 1081
2012 1157
2013 1356
2014 1422
2015 1381
2016 1470
2017 1534
2018 1688
2019 1840
2020 1983
2021 2187
2022 2453
2023 2256
2024 2374
2025 387

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,370 results

Results by year

Filters applied: . Clear all
Page 1
TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
Zheng J, Wang L, Zhao S, Zhang W, Chang Y, Bosco DB, Huang T, Dheer A, Gao S, Xu S, Ayasoufi K, Al-Kharboosh R, Qi F, Xie M, Johnson AJ, Dong H, Quiñones-Hinojosa A, Wu LJ. Zheng J, et al. Among authors: chang y. Neuro Oncol. 2024 May 3;26(5):811-825. doi: 10.1093/neuonc/noad214. Neuro Oncol. 2024. PMID: 37941134 Free PMC article.
Dyslipidemia management update.
Chang Y, Robidoux J. Chang Y, et al. Curr Opin Pharmacol. 2017 Apr;33:47-55. doi: 10.1016/j.coph.2017.04.005. Epub 2017 May 17. Curr Opin Pharmacol. 2017. PMID: 28527325 Review.
COVID-19 and allergy.
Chang YS. Chang YS. Asia Pac Allergy. 2020 Jul 30;10(3):e34. doi: 10.5415/apallergy.2020.10.e34. eCollection 2020 Jul. Asia Pac Allergy. 2020. PMID: 32789119 Free PMC article. No abstract available.
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma.
Casillo SM, Gatesman TA, Chilukuri A, Varadharajan S, Johnson BJ, David Premkumar DR, Jane EP, Plute TJ, Koncar RF, Stanton AJ, Biagi-Junior CAO, Barber CS, Halbert ME, Golbourn BJ, Halligan K, Cruz AF, Mansi NM, Cheney A, Mullett SJ, Land CV, Perez JL, Myers MI, Agrawal N, Michel JJ, Chang YF, Vaske OM, MichaelRaj A, Lieberman FS, Felker J, Shiva S, Bertrand KC, Amankulor N, Hadjipanayis CG, Abdullah KG, Zinn PO, Friedlander RM, Abel TJ, Nazarian J, Venneti S, Filbin MG, Gelhaus SL, Mack SC, Pollack IF, Agnihotri S. Casillo SM, et al. Among authors: chang yf. Cell Rep. 2024 Jan 23;43(1):113557. doi: 10.1016/j.celrep.2023.113557. Epub 2023 Dec 18. Cell Rep. 2024. PMID: 38113141 Free article.
Phospholipase A2 superfamily in cancer.
Peng Z, Chang Y, Fan J, Ji W, Su C. Peng Z, et al. Among authors: chang y. Cancer Lett. 2021 Jan 28;497:165-177. doi: 10.1016/j.canlet.2020.10.021. Epub 2020 Oct 17. Cancer Lett. 2021. PMID: 33080311 Review.
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Bao Y, Qiao Y, Choi JE, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove S, Cao X, Su F, Wang R, Chang Y, Kryczek I, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Bao Y, et al. Among authors: chang y. Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2314416120. doi: 10.1073/pnas.2314416120. Epub 2023 Nov 27. Proc Natl Acad Sci U S A. 2023. PMID: 38011559 Free PMC article.
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes.
Parker VER, Robertson D, Erazo-Tapia E, Havekes B, Phielix E, de Ligt M, Roumans KHM, Mevenkamp J, Sjoberg F, Schrauwen-Hinderling VB, Johansson E, Chang YT, Esterline R, Smith K, Wilkinson DJ, Hansen L, Johansson L, Ambery P, Jermutus L, Schrauwen P. Parker VER, et al. Among authors: chang yt. Nat Metab. 2023 Dec;5(12):2086-2093. doi: 10.1038/s42255-023-00938-0. Epub 2023 Dec 8. Nat Metab. 2023. PMID: 38066113 Free PMC article. Clinical Trial.
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Das A, Fernandez NR, Levine A, Bianchi V, Stengs LK, Chung J, Negm L, Dimayacyac JR, Chang Y, Nobre L, Ercan AB, Sanchez-Ramirez S, Sudhaman S, Edwards M, Larouche V, Samuel D, Van Damme A, Gass D, Ziegler DS, Bielack SS, Koschmann C, Zelcer S, Yalon-Oren M, Campino GA, Sarosiek T, Nichols KE, Loret De Mola R, Bielamowicz K, Sabel M, Frojd CA, Wood MD, Glover JM, Lee YY, Vanan M, Adamski JK, Perreault S, Chamdine O, Hjort MA, Zapotocky M, Carceller F, Wright E, Fedorakova I, Lossos A, Tanaka R, Osborn M, Blumenthal DT, Aronson M, Bartels U, Huang A, Ramaswamy V, Malkin D, Shlien A, Villani A, Dirks PB, Pugh TJ, Getz G, Maruvka YE, Tsang DS, Ertl-Wagner B, Hawkins C, Bouffet E, Morgenstern DA, Tabori U. Das A, et al. Among authors: chang y. Cancer Discov. 2024 Feb 8;14(2):258-273. doi: 10.1158/2159-8290.CD-23-0559. Cancer Discov. 2024. PMID: 37823831 Free PMC article.
Nanomedicine-mediated regulated cell death in cancer immunotherapy.
Sun Y, Lian T, Huang Q, Chang Y, Li Y, Guo X, Kong W, Yang Y, Zhang K, Wang P, Wang X. Sun Y, et al. Among authors: chang y. J Control Release. 2023 Dec;364:174-194. doi: 10.1016/j.jconrel.2023.10.032. Epub 2023 Oct 27. J Control Release. 2023. PMID: 37871752 Review.
28,370 results
You have reached the last available page of results. Please see the User Guide for more information.